Matrix metalloproteinases: multifunctional contributors to tumor progression

Lukashev, 1998, ECM signalling: orchestrating cell behaviour and misbehaviour, Trends Cell Biol., 8, 437, 10.1016/S0962-8924(98)01362-2 Nagase, 1999, Matrix metalloproteinases, J. Biol. Chem., 274, 21491, 10.1074/jbc.274.31.21491 Fidler, 1997, Molecular biology of cancer: invasion and metastasis, 135 Schwarzbauer, 1999, Basement membranes: Putting up the barriers, Curr. Biol., 9, R242, 10.1016/S0960-9822(99)80153-5 Stetler-Stevenson, 1996, Matrix metalloproteinases and tumor invasion – from correlation and causality to the clinic, Semin. Cancer Biol., 7, 147, 10.1006/scbi.1996.0020 Massova, 1998, Matrix metalloproteinases: structures, evolution, and diversification, FASEB J., 12, 1075, 10.1096/fasebj.12.12.1075 Lovejoy, 1994, Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor, Science, 263, 375, 10.1126/science.8278810 Sanchez-Lopez, 1993, Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins, J. Biol. Chem., 268, 7238, 10.1016/S0021-9258(18)53168-9 Baragi, 1994, Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin, J. Biol. Chem., 269, 12692, 10.1016/S0021-9258(18)99931-X Ward, 1994, Cell surface-mediated activation of progelatinase A: Demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts, Biochem. J., 304, 263, 10.1042/bj3040263 Murphy, 1994, Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant, J. Biol. Chem., 269, 6632, 10.1016/S0021-9258(17)37419-7 Sato, 1994, A matrix metalloproteinase expressed on the surface of invasive tumour cells, Nature, 370, 61, 10.1038/370061a0 Edwards, 1996, The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth, Int. J. Obes., 20, S9 Gomez, 1997, Tissue inhibitors of metalloproteinases: structure, regulation and biological function, Eur. J. Cell Biol., 74, 111 Brown, 1997, Matrix metalloproteinase inhibitors, Angiogenesis, 1, 142, 10.1023/A:1018373520193 Gross, 1962, Collagenolytic activity in amphibian tissues: a tissue culture assay, Proc. Natl. Acad. Sci. U. S. A., 48, 1014, 10.1073/pnas.48.6.1014 Hulboy, 1997, Matrix metalloproteinases as mediators of reproductive function, Mol. Hum. Reprod., 3, 27, 10.1093/molehr/3.1.27 Jones, 1999, The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer, Ann. New York Acad. Sci., 880, 288, 10.1111/j.1749-6632.1999.tb09533.x Drummond, 1999, Preclinical and clinical studies of MMP inhibitors in cancer, Ann. New York Acad. Sci., 878, 228, 10.1111/j.1749-6632.1999.tb07688.x Shalinsky, 1999, Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials, Ann. New York Acad. Sci., 878, 236, 10.1111/j.1749-6632.1999.tb07689.x Matrisian, 1986, Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts, Mol. Cell. Biol., 6, 1679, 10.1128/MCB.6.5.1679 Crawford, 1996, Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells, Enzyme Protein, 49, 20, 10.1159/000468614 Liotta, 1980, Metastatic potential correlates with enzymatic degradation of basement membrane collagen, Nature, 284, 67, 10.1038/284067a0 Nakajima, 1987, Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials, Cancer Res., 47, 4869 Lochter, 1997, Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells, J. Cell Biol., 139, 1861, 10.1083/jcb.139.7.1861 Sternlicht, 1999, The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis, Cell, 98, 137, 10.1016/S0092-8674(00)81009-0 Murphy, 1993, Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation, J. Cell. Physiol., 157, 351, 10.1002/jcp.1041570219 Alvarez, 1990, Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases, J, Natl. Cancer Inst., 82, 589, 10.1093/jnci/82.7.589 Khokha, 1994, Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1, J. Natl. Cancer Inst., 86, 299, 10.1093/jnci/86.4.299 Yoneda, 1997, Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2, J. Clin. Invest., 99, 2509, 10.1172/JCI119435 Chambers, 1997, Changing views of the role of matrix metalloproteinases in metastasis, J. Natl. Cancer Inst., 89, 1260, 10.1093/jnci/89.17.1260 Koop, 1994, Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth, Cancer Res., 54, 4791 Wylie, 1998, The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastasis of B16F1 melanoma cells, Clin. Exp. Metastasis, 17, 111, 10.1023/A:1006573417179 Xia, 1996, Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides, Biochim. Biophys. Acta., 1293, 259, 10.1016/0167-4838(95)00259-6 Biswas, 1995, The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily, Cancer Res., 55, 434 Rudolph-Owen, 1998, The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis, Cancer Res., 58, 5500 D’Armiento, 1995, Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis, Mol. Cell. Biol., 15, 5732, 10.1128/MCB.15.10.5732 Wilson, 1997, Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin, Proc. Natl. Acad. Sci. U. S. A., 94, 1402, 10.1073/pnas.94.4.1402 Masson, 1998, In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy, J. Cell Biol., 140, 1535, 10.1083/jcb.140.6.1535 Stetler-Stevenson, 1999, Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention, J. Clin. Invest., 103, 1237, 10.1172/JCI6870 Brooks, 1998, Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity, Cell, 92, 391, 10.1016/S0092-8674(00)80931-9 Itoh, 1998, Reduced angiogenesis and tumor progression in gelatinase A-deficient mice, Cancer Res., 58, 1048 Giancotti, 1999, Integrin signaling, Science, 285, 1028, 10.1126/science.285.5430.1028 Montgomery, 1994, Integrin αvβ3 rescues melanoma cells from apoptosis in a three-dimensional dermal collagen, Proc. Natl. Acad. Sci. U. S. A., 91, 8856, 10.1073/pnas.91.19.8856 Giannelli, 1997, Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5, Science, 277, 225, 10.1126/science.277.5323.225 Imai, 1997, Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release, Biochem. J., 322, 809, 10.1042/bj3220809 Ugwu, 1998, Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3), Biochemistry, 37, 7231, 10.1021/bi9728708 von Bredow, 1997, Cleavage of beta 4 integrin by matrilysin, Exp. Cell Res., 236, 341, 10.1006/excr.1997.3711 Birchmeier, 1995, E-cadherin as a tumor (invasion) suppressor gene, BioEssays, 17, 97, 10.1002/bies.950170203 Suzuki, 1997, Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site, J. Biol. Chem., 272, 31730, 10.1074/jbc.272.50.31730 Levi, 1996, Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1, Proc. Natl. Acad. Sci. U. S. A., 93, 7069, 10.1073/pnas.93.14.7069 Schonbeck, 1998, Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing, J. Immunol., 161, 3340, 10.4049/jimmunol.161.7.3340 Fowlkes, 1994, Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures, J. Biol. Chem., 269, 25742, 10.1016/S0021-9258(18)47310-3 Bergers, 1999, Effects of angiogenesis inhibitors on multistage carcinogenesis in mice, Science, 284, 808, 10.1126/science.284.5415.808